2014
DOI: 10.1074/jbc.m113.497909
|View full text |Cite
|
Sign up to set email alerts
|

Cognitive Deficits and Disruption of Neurogenesis in a Mouse Model of Apolipoprotein E4 Domain Interaction

Abstract: Background: Domain interaction may be the principal pathogenic feature of apoE4 in Alzheimer disease. Results: Young and old mice with mutations causing apoE4 domain interaction showed impaired cognition and a disruption in neurogenesis. Conclusion: Domain interaction mediates apoE4 neuro-pathologies and cognitive phenotype. Significance: Domain interaction is a viable prophylactic target against apoE4 cognitive phenotype and increased susceptibility to Alzheimer disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
38
2

Year Published

2014
2014
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(43 citation statements)
references
References 103 publications
(100 reference statements)
3
38
2
Order By: Relevance
“…Unfortunately, we did not evaluate mice cognition in the present study and therefore, we cannot confirm this speculationi.e. cognitive impairments in APOE4 mice [39,40]. Also, the activity of FATPs, FABPs and CPT1 remains to be further investigated since only the levels, and not activities, were measured in the present study.…”
Section: Discussionmentioning
confidence: 94%
“…Unfortunately, we did not evaluate mice cognition in the present study and therefore, we cannot confirm this speculationi.e. cognitive impairments in APOE4 mice [39,40]. Also, the activity of FATPs, FABPs and CPT1 remains to be further investigated since only the levels, and not activities, were measured in the present study.…”
Section: Discussionmentioning
confidence: 94%
“…Neurogenesis which has been shown to be involved in cognitive impairment and depression in humans and in a variety of rodent models, is a function of serotonergic regulation and may affect the response to antidepressants in both cognitive and affective behavioral domains (Adeosun et al, 2014;Alenina and Klempin, 2015;Anacker, 2014;Biscaro et al, 2012;Braun and Jessberger, 2014;Chadwick et al, 2011;Cho et al, 2015;Dimitrov et al, 2014;Gundersen et al, 2013;Hill et al, 2015;Jiang et al, 2015;Lin and Wang, 2014;Mendez-David et al, 2013;Morais et al, 2014;O'Leary and Cryan, 2014;Parihar et al, 2013;Pereira Dias et al, 2014;Ransome et al, 2012;Rotheneichner et al, 2014;Schoenfeld and Cameron, 2015;Seib et al, 2013;Serafini et al, 2014;Shetty, 2014;Suarez-Pereira et al, 2015;Yau et al, 2014). In young adult mice, antidepressants increase stem cell proliferation (Hodes et al, 2010;Santarelli et al, 2003;Tanti et al, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Neurogenesis appears to be increased in young animals and decreased with age, while apoptotic markers indicate enhanced cell death. Interestingly, these early cognitive and cellular changes take place in the absence of classical AD pathological hallmarks (Adeosun et al 2014). In another study, deletion of ApoE in mice results in reduced neurogenesis and knock-in of the human ApoE4 leads to impaired maturation of newborn neurons through a mechanism dependent on GABAergic signaling (Li et al 2009).…”
Section: Age-related Cognitive and Neurogenesis Decline In Animalsmentioning
confidence: 99%